The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Desloratadine Market Research Report 2025
Synopsis
Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis.
The global Desloratadine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Desloratadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Desloratadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Desloratadine include Vasudha Pharma, Divis Labs, Sun Pharma, Lupin, Mylan, Cadila Pharma, Dr. Reddy's, Cipla and Orchid Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Desloratadine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine.
Report Scope
The Desloratadine market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Desloratadine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desloratadine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vasudha Pharma
Divis Labs
Sun Pharma
Lupin
Mylan
Cadila Pharma
Dr. Reddy's
Cipla
Orchid Pharma
Tapi Teva
Farmhispania
Hainan Poly Pharm
Suanfarma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Desloratadine Oral Solution
Desloratadine Oral Tablet
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Desloratadine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Desloratadine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Desloratadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis.
The global Desloratadine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Desloratadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Desloratadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Desloratadine include Vasudha Pharma, Divis Labs, Sun Pharma, Lupin, Mylan, Cadila Pharma, Dr. Reddy's, Cipla and Orchid Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Desloratadine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine.
Report Scope
The Desloratadine market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Desloratadine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desloratadine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vasudha Pharma
Divis Labs
Sun Pharma
Lupin
Mylan
Cadila Pharma
Dr. Reddy's
Cipla
Orchid Pharma
Tapi Teva
Farmhispania
Hainan Poly Pharm
Suanfarma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Desloratadine Oral Solution
Desloratadine Oral Tablet
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Desloratadine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Desloratadine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Desloratadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Desloratadine Market Overview
1.1 Product Definition
1.2 Desloratadine Segment by Type
1.2.1 Global Desloratadine Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Desloratadine Segment by Application
1.3.1 Global Desloratadine Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Desloratadine Oral Solution
1.3.3 Desloratadine Oral Tablet
1.4 Global Market Growth Prospects
1.4.1 Global Desloratadine Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Desloratadine Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Desloratadine Production Estimates and Forecasts (2019-2030)
1.4.4 Global Desloratadine Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Desloratadine Production Market Share by Manufacturers (2019-2024)
2.2 Global Desloratadine Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Desloratadine, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Desloratadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Desloratadine Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Desloratadine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Desloratadine, Product Offered and Application
2.8 Global Key Manufacturers of Desloratadine, Date of Enter into This Industry
2.9 Desloratadine Market Competitive Situation and Trends
2.9.1 Desloratadine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Desloratadine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Desloratadine Production by Region
3.1 Global Desloratadine Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Desloratadine Production Value by Region (2019-2030)
3.2.1 Global Desloratadine Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Desloratadine by Region (2025-2030)
3.3 Global Desloratadine Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Desloratadine Production by Region (2019-2030)
3.4.1 Global Desloratadine Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Desloratadine by Region (2025-2030)
3.5 Global Desloratadine Market Price Analysis by Region (2019-2024)
3.6 Global Desloratadine Production and Value, Year-over-Year Growth
3.6.1 North America Desloratadine Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Desloratadine Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Desloratadine Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Desloratadine Production Value Estimates and Forecasts (2019-2030)
4 Desloratadine Consumption by Region
4.1 Global Desloratadine Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Desloratadine Consumption by Region (2019-2030)
4.2.1 Global Desloratadine Consumption by Region (2019-2024)
4.2.2 Global Desloratadine Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Desloratadine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Desloratadine Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Desloratadine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Desloratadine Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Desloratadine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Desloratadine Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Desloratadine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Desloratadine Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Desloratadine Production by Type (2019-2030)
5.1.1 Global Desloratadine Production by Type (2019-2024)
5.1.2 Global Desloratadine Production by Type (2025-2030)
5.1.3 Global Desloratadine Production Market Share by Type (2019-2030)
5.2 Global Desloratadine Production Value by Type (2019-2030)
5.2.1 Global Desloratadine Production Value by Type (2019-2024)
5.2.2 Global Desloratadine Production Value by Type (2025-2030)
5.2.3 Global Desloratadine Production Value Market Share by Type (2019-2030)
5.3 Global Desloratadine Price by Type (2019-2030)
6 Segment by Application
6.1 Global Desloratadine Production by Application (2019-2030)
6.1.1 Global Desloratadine Production by Application (2019-2024)
6.1.2 Global Desloratadine Production by Application (2025-2030)
6.1.3 Global Desloratadine Production Market Share by Application (2019-2030)
6.2 Global Desloratadine Production Value by Application (2019-2030)
6.2.1 Global Desloratadine Production Value by Application (2019-2024)
6.2.2 Global Desloratadine Production Value by Application (2025-2030)
6.2.3 Global Desloratadine Production Value Market Share by Application (2019-2030)
6.3 Global Desloratadine Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Vasudha Pharma
7.1.1 Vasudha Pharma Desloratadine Corporation Information
7.1.2 Vasudha Pharma Desloratadine Product Portfolio
7.1.3 Vasudha Pharma Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Vasudha Pharma Main Business and Markets Served
7.1.5 Vasudha Pharma Recent Developments/Updates
7.2 Divis Labs
7.2.1 Divis Labs Desloratadine Corporation Information
7.2.2 Divis Labs Desloratadine Product Portfolio
7.2.3 Divis Labs Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Divis Labs Main Business and Markets Served
7.2.5 Divis Labs Recent Developments/Updates
7.3 Sun Pharma
7.3.1 Sun Pharma Desloratadine Corporation Information
7.3.2 Sun Pharma Desloratadine Product Portfolio
7.3.3 Sun Pharma Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Sun Pharma Main Business and Markets Served
7.3.5 Sun Pharma Recent Developments/Updates
7.4 Lupin
7.4.1 Lupin Desloratadine Corporation Information
7.4.2 Lupin Desloratadine Product Portfolio
7.4.3 Lupin Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Lupin Main Business and Markets Served
7.4.5 Lupin Recent Developments/Updates
7.5 Mylan
7.5.1 Mylan Desloratadine Corporation Information
7.5.2 Mylan Desloratadine Product Portfolio
7.5.3 Mylan Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Mylan Main Business and Markets Served
7.5.5 Mylan Recent Developments/Updates
7.6 Cadila Pharma
7.6.1 Cadila Pharma Desloratadine Corporation Information
7.6.2 Cadila Pharma Desloratadine Product Portfolio
7.6.3 Cadila Pharma Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Cadila Pharma Main Business and Markets Served
7.6.5 Cadila Pharma Recent Developments/Updates
7.7 Dr. Reddy's
7.7.1 Dr. Reddy's Desloratadine Corporation Information
7.7.2 Dr. Reddy's Desloratadine Product Portfolio
7.7.3 Dr. Reddy's Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Dr. Reddy's Main Business and Markets Served
7.7.5 Dr. Reddy's Recent Developments/Updates
7.8 Cipla
7.8.1 Cipla Desloratadine Corporation Information
7.8.2 Cipla Desloratadine Product Portfolio
7.8.3 Cipla Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Cipla Main Business and Markets Served
7.7.5 Cipla Recent Developments/Updates
7.9 Orchid Pharma
7.9.1 Orchid Pharma Desloratadine Corporation Information
7.9.2 Orchid Pharma Desloratadine Product Portfolio
7.9.3 Orchid Pharma Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Orchid Pharma Main Business and Markets Served
7.9.5 Orchid Pharma Recent Developments/Updates
7.10 Tapi Teva
7.10.1 Tapi Teva Desloratadine Corporation Information
7.10.2 Tapi Teva Desloratadine Product Portfolio
7.10.3 Tapi Teva Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Tapi Teva Main Business and Markets Served
7.10.5 Tapi Teva Recent Developments/Updates
7.11 Farmhispania
7.11.1 Farmhispania Desloratadine Corporation Information
7.11.2 Farmhispania Desloratadine Product Portfolio
7.11.3 Farmhispania Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Farmhispania Main Business and Markets Served
7.11.5 Farmhispania Recent Developments/Updates
7.12 Hainan Poly Pharm
7.12.1 Hainan Poly Pharm Desloratadine Corporation Information
7.12.2 Hainan Poly Pharm Desloratadine Product Portfolio
7.12.3 Hainan Poly Pharm Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Hainan Poly Pharm Main Business and Markets Served
7.12.5 Hainan Poly Pharm Recent Developments/Updates
7.13 Suanfarma
7.13.1 Suanfarma Desloratadine Corporation Information
7.13.2 Suanfarma Desloratadine Product Portfolio
7.13.3 Suanfarma Desloratadine Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Suanfarma Main Business and Markets Served
7.13.5 Suanfarma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Desloratadine Industry Chain Analysis
8.2 Desloratadine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Desloratadine Production Mode & Process
8.4 Desloratadine Sales and Marketing
8.4.1 Desloratadine Sales Channels
8.4.2 Desloratadine Distributors
8.5 Desloratadine Customers
9 Desloratadine Market Dynamics
9.1 Desloratadine Industry Trends
9.2 Desloratadine Market Drivers
9.3 Desloratadine Market Challenges
9.4 Desloratadine Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
